We aim to Provide facts about the vaccination coverage for combined vaccines such as MMR (Measles, Mumps and Rubella) and DTP (Diphtheria, Tetanus, Pertussis) containing vaccines in use in Albania during the last 10 years, in order to confirm the stability of immunization program. One of the reasons for coverage improvement is the use of one or two-dose vials for the administration of MMR vaccine, enabling the vaccination of children at any time, without the need of gathering them on certain days when the multi-dose vaccine vials are opened. In the last three years, according to WHO recommendations, it was noted that vaccination coverage with three doses containing DTP is at sustainable levels, always above 95%, but for our country this value goes sometimes above 98%. As for the use of pentavalent vaccine, from 2008, DTP-HepB-Hib, also the coverage of Hepatitis b vaccine is always at upper levels due to its use on 5 in 1 combination. The application of this vaccine was associated with the use of one dose vial administration, therefore one vaccine to a child. Immunization coverage for vaccines with measles component remains at very high levels for both doses of vaccine, more then 95%. Immunization coverage for vaccines with DTP component exceeds 95% rate at country level, for each district it exceeds 95% and it reaches the value of 98.5% for the last two years. During the last years the vaccine coverage is increased significantly as a result of using combined vaccine of DTP-HepB -Hib. The use of one dose vials has played an important role on sustaininig and increasing vaccination coverage.
Keywords: MMR, DTP, combined vaccine, vaccination coverage

Introduction
In Albania, the measles vaccine has been in regular use since 1971 as a single antigen. Due to the epidemic outbreak of 1970-71, a mass vaccination, with the imported B55 vaccine, was urgently taken for the first time in Albania, for all groups of children born in the period 1956-1970. In 1971 induced routine vaccination against measles was introduced in the national immunization schedule for all new births that would follow and in 1977 measles vaccine began to be produced even in the country.
In 1992, domestic production of B55 vaccine was interrupted, being replaced by the imported Schwarz vaccine. Since January 200, Albania has introduced the bi-valent measles and rubella vaccine in the compulsory vaccination calendar (Kakarriqi, 2002) giving the child a basic dose on the 12th month of birth and the booster dose at age of 5. Mumps component was added to the National Immunization Program since January 2005 with the introduction of the three-valent vaccine, which is still in use in Albania today.
Measles is considered as a disease that could disappear because of a single serotype, effective vaccine, lack of human natural reservoirs and high clinical expression of the disease. For years an attempt has been made to eliminate measles through continuous vaccination to prevent its recurrence achieving so the "herd" immunity. Global eradication will be based on the successful elimination in all countries.
The most recent assessment by WHO for measles vaccine coverage ( Figure 1) shows that globally the values are over 90% mostly in American and European regions. Much work remains to be done in order to increase vaccine coverage in the African region and partly in the Asian one (WHO, 2016). 
Materials and Methods
Routine levels of vaccination coverage indicate the vaccination program performance and provide an overview of immunity in the population. Immunization coverage is usually assessed on the basis of the percentage of children who have received a certain number of recommended vaccine dose during the first year of life. In the same way, the vaccination coverage is also evaluated for the recommended vaccines doses for revaccination (reminder immune). This vaccination coverage is nothing but a report of the number of children vaccinated versus the number of children scheduled for vaccination. The reported covarage data taken from the vaccination centers are aggregated to higher levels by providing values at the district, prefecture and national levels. (WHO, 2010) In this study, we tried to provide facts about the vaccine coverage for combined vaccines such as MMR and DTP containing vaccines in use in Albania during the last 10 years, in order to confirm the stability of immunization program.
The percentage of vaccine coverage for each vaccination (immunization) indicator in all districts of the country during the years 2003-2013, for each antigen obtained in the study.
Immunization coverage in percentage is calculated by the formula:
Results:
In the context of eliminating measles (Kakarriqi and Bino, 2002) , an important factor for vaccine coverage is its level over 95% at country level and at the district level over 90%, or vaccination coverage 90% for two doses of vaccine containing component of measles, for all children until 2015.
MR vaccine was used in the years 2003-2004 and then, from 2005 until now the MMR vaccine has been used in the national immunization calendar (Bino et al, 2003) .
Graphically this coverage is presented in the following graph (1) where it is obvious that this coverage for both doses exceeds levels of 95%, except for 2006, during which the national program of vaccination was faced with a shortage of this vaccine globally and exactly in this year two measles outbreaks occurred, mainly in the Roma population of Saranda and Elbasan districts.
Furthermore, a reason for the improvement of this coverage is the use of one dose bottles administration for MMR vaccine, enabling the vaccination of children at any time, without the need of collecting them on certain days when the vaccine bottles are opened. Although in the global strategy for the elimination of measles (Hall and Jolley, 2011) the vaccination coverage in every district should be above 90%, for our country it is clearly seen that this coverage is in very high levels, i.e. well above 95%. For the first dose the average value is 98.8% and with IC [98.4% -99.3%], which shows that vaccination coverage is also high at the district level. (Graph.1) It is worth mentioning that since 2009 the hepatitis B component was included in the combined pentavalent DTP-HepB-Hib vaccine.
As it is seen even graphically, this coverage is above 95% of the value according to WHO recommendations (WHO, 2014), but for our country, the average value is 98.3% with IC [98.0% -98.5%], which indicates a very high level of coverage with this vaccine, already combined 5 in 1.
Graph 2. Vaccination coverage for the third dose of hepatitis B, 2003-2013
Especially considering the last three years, it is noted that vaccination coverage with three doses of vaccine containing hepatitis B is at sustainable levels (Nelaj et al, 2014) always above 95%, according to the recommendations of the WHO, but for our country this value reaches above 98 %. One of the factors of reaching high levels is the use of the combined vaccine 5 in 1, enabling child vaccination with only one injection. The other reason is that since 2008, the introduction of this vaccine was associated with its use in one-vial dose administration, that ia to say, a vaccine to a child. Some years ago, mainly in the rural areas, vaccination centers used the practice of approximate date of vaccination by assembling children for vaccination in one or two days a month, so there was no significant loss in the use of the multi-dose bottle; while by using one-dose bottle vaccines the child is vaccinated almost exactly on the appointed day, with rare exceptions, when vaccination is postponed for health reasons.
Graphical presentation clearly demonstrates the viability of the vaccine in very high levels. Graph 3 clearly shows that high levels of this coverage are reflected by the very high coverage in each district of the country, where the coverage values go beyond the 98%. Specifically the average value is 99.2% with IC [98.9% -99.5%].
DTP vaccination coverage for Albania
As it was mentioned in the previous evaluation of the coverage for other vaccine antigens, in the immunization global strategy (WHO,2016), the important factor for vaccine coverage is its value over 95% at the national level and at the district level above 90% for the three vaccine doses containing diphtheria, tetanus and pertus.
For the evaluation of vaccine coverage, the application of the third dose with DTP component is taken into consideration, since it means the fulfillment of a series of vaccination with this vaccine, according to the national immunization schedule. Immunization coverage for three applied vaccine doses with DTP component for the years 2003-2013 appears to be above 95% at the country and district level. As it was mentined, since 2009, DTP components were included in the pentavalent DTP-HepB-Hib combined vaccine.
It is clearly seen that the level of vaccine coverage for these components (Graph 4) exceeds the value of 95%, reaching in some cases 99% values. The average value turns out to be 98.3% Graph 4. Immunization coverage for DTP components, 2003 DTP components, -2013 According to the calendar, at the two-month age the revaccination with DTP vaccine (diphtheria tetanus, pertus) is applied. Graph 5 shows the values of DTP vaccine coverage for the first booster dose. It is obviously seen that at the age of 2 vaccination with this vaccine retains (maintains) the same trend, i.e. vaccination coverage, not just 95% but more than 97%. Graph 6 shows the immuniztion coverage for DT in the second booster dose. Vaccination in this age retains again the same trend, more than 97%. One strong reason for maintaining these levels is the fact that children ought to be vaccinated before staring the primary school; they are strongly obliged to present their immunization records before their enrollment in schools.
At the age of 14, as marked in the calendar, the third booster dose (tetanus, with less diphtheria) happens. Graph 
